University of St Andrews

Mackenzie Institute for Early Diagnosis

EBED 2024 – Programme 

Wednesday 29 May

TimelineTopic
1200-1300Arrival and lunch
1300-1315Welcome and introduction from Prof. Peter Donnelly
1315-1415Setting the Scene: what could success look like for the introduction of new diagnostic tests?
Patient Representative - Anne Fearfull
Industry Representative - Andreas Halner, Oxford Cancer Analytics (OXcan)
Regulator Representative - Joseph Burt, Medicines and Healthcare products Regulatory Agency (MHRA)
British Medical Journal – Helen Macdonald
1415-1530Theoretical Considerations
Dr. Margaret McCartney, Senior Lecturer, University of St Andrews, freelance writer and broadcaster
Prof. John Brodersen, University of Copenhagen, Department of Public Health
30 mins moderated panel discussion of 1st 2 sessions
1530-1600BREAK
1600-1715Abstract Session
Elevator Pitches
1715-1830Clinical Perspective
Prof. Carl Heneghan, Centre for Evidence-Based medicine, University of Oxford
Prof. Susan Moug, University of Glasgow, School of Medicine, Dentistry and Nursing
Prof Alex Richter, Birmingham JD
Discussion
1830Drinks Reception in the Gateway, followed by walking tour of St Andrews led by University Students

Thursday 30 May

TimelineTopic
0715-Beach run/swim with Dr. Margaret McCartney & Prof. Frank Sullivan – Meet at Gateway Building
0800-0900Networking coffee time
0900-1030Policy and Regulations
Prof. Jon Deeks, University of Birmingham, Institute of Applied Health Research
Dr. Stuart Hogarth, Cambridge MMcC
Discussion
1030-1100BREAK
1100-1200Economic Issues
Rebecca Fitzgerald Pd
Prof. Bethany Shinkins, Warwick Medical School Health Sciences
Discussion
1200-1300Lunch and networking
1300-1430Abstract Session
Theoretical considerations
1430-1500BREAK
1500-1600Abstract Session
Clinical & patient perspective
1600-1730Meet the expert Sessions FS
Facilitators:
1. Associate Prof. Brian Nicholson, Nuffield Department of Primary Care Health Symplify Sciences, University of Oxford
a. How should we evaluate novel cancer
2. Prof. Clare Turnbull, The Institute of Cancer Research Polygenic testing
a. What can polygenic testing contribute to ED
3. Bob Steele NSC
a. How the NSC decides whether a screening programme should be implemented
4. Chris Peters Biomarkers
a. Why so few biomarkers make it into clinical practice.
Feedback
1730-1800Tour of Medicine Building
1900Conference dinner

Friday 31 May

TimelineTopic
0800-0900Networking coffee time
0900-1000Abstract Session
Policy & Regulation
1000-1030BREAK
1030-1200Small Group Session Feedback: identifying gaps and how to take forward
Questions not answered earlier on the discussions
Theory
Clinical
Policy economic

Feedback from Meet the experts and Small group gap discussions
1200-1230Summary and Future Planning
1230-1400Lunch, Safe journey home
X